Canadian Cancer Trials Group Bulletins


Recent Publications

December 2008:
Zhang W, Seymour L, Chen EX. Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 876: 277-82, 2008. (note: you must select volume)

Bjarnason GA, MacKenzie RG, Nabid A, Hodson ID, El-Sayed SM, Grimard L, Brundage M, Wright J, Hay J, Ganguly P, Leong C, Wilson J, Jordan RCK, Walker M, Tu D, Parulekar W. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: A prospective randomized trial of the Canadian Cancer Trials Group (HN3). Int J Rad Oncol Biol Phys 73(1): 166-72, 2009. (note: you must select volume)

and associated Editorial:
Haus, E. Chronobiology in oncology. Int J Rad Oncol Biol Phys 73(1): 3-5, 2009. (note: you must select volume)

Eisenhauer E, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. New response evaluation criteria in solid tumors: Revised RECIST guideline version 1.1. Eur J Can 45: 228-47, 2009.

Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T, Zheng Y, Green E, Labianca R, O'Callaghan C, Seitz JF, Francini G, Haller D, Yothers G, Goldberg R, de Gramont A. Evidence for cure by adjuvant therapy in colon cancer: Observations based on individual patient data from 20,898 patients on 18 randomized trials (ONLINE). J Clin Oncol 2009.